Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of interleukin-12 production (GO:0032695) | 5.18269640 |
2 | modulation by symbiont of host defense response (GO:0052031) | 4.65619934 |
3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.65619934 |
4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.65619934 |
5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.65619934 |
6 | modulation by symbiont of host immune response (GO:0052553) | 4.65619934 |
7 | positive regulation by symbiont of host defense response (GO:0052509) | 4.65619934 |
8 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.54541190 |
9 | regulation of mononuclear cell migration (GO:0071675) | 4.53678965 |
10 | microglial cell activation (GO:0001774) | 4.45975301 |
11 | complement activation, alternative pathway (GO:0006957) | 4.06820156 |
12 | oligosaccharide catabolic process (GO:0009313) | 4.06161894 |
13 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.98017380 |
14 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.95773372 |
15 | macrophage activation involved in immune response (GO:0002281) | 3.89610862 |
16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.72728658 |
17 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.72625167 |
18 | positive regulation of mast cell activation (GO:0033005) | 3.71801995 |
19 | L-phenylalanine catabolic process (GO:0006559) | 3.67700490 |
20 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.67700490 |
21 | positive regulation of mast cell degranulation (GO:0043306) | 3.66924807 |
22 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.66924807 |
23 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.65807263 |
24 | macrophage activation (GO:0042116) | 3.62583606 |
25 | regulation of mast cell degranulation (GO:0043304) | 3.61580028 |
26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.59934860 |
27 | protein carboxylation (GO:0018214) | 3.59934860 |
28 | amino sugar catabolic process (GO:0046348) | 3.58478815 |
29 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.56532356 |
30 | negative regulation of granulocyte differentiation (GO:0030853) | 3.53804081 |
31 | positive regulation of leukocyte degranulation (GO:0043302) | 3.48890731 |
32 | phospholipid efflux (GO:0033700) | 3.46020653 |
33 | glycolipid catabolic process (GO:0019377) | 3.43574681 |
34 | detection of other organism (GO:0098543) | 3.43443503 |
35 | N-acetylneuraminate metabolic process (GO:0006054) | 3.39043133 |
36 | negative regulation of cell killing (GO:0031342) | 3.38705333 |
37 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.38705333 |
38 | immunoglobulin mediated immune response (GO:0016064) | 3.37358710 |
39 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.35989490 |
40 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.35512463 |
41 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.33405735 |
42 | L-phenylalanine metabolic process (GO:0006558) | 3.33405735 |
43 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.33059136 |
44 | positive regulation of chemokine secretion (GO:0090197) | 3.29837537 |
45 | regulation of leukocyte degranulation (GO:0043300) | 3.27990977 |
46 | T-helper 1 type immune response (GO:0042088) | 3.26093025 |
47 | detection of external biotic stimulus (GO:0098581) | 3.25379602 |
48 | regulation of mast cell activation (GO:0033003) | 3.21601905 |
49 | Golgi transport vesicle coating (GO:0048200) | 3.20870975 |
50 | COPI coating of Golgi vesicle (GO:0048205) | 3.20870975 |
51 | granulocyte activation (GO:0036230) | 3.18680900 |
52 | apoptotic cell clearance (GO:0043277) | 3.14251242 |
53 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.13838877 |
54 | complement activation (GO:0006956) | 3.12229970 |
55 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.11166087 |
56 | detection of biotic stimulus (GO:0009595) | 3.10897309 |
57 | response to thyroid hormone (GO:0097066) | 3.10731159 |
58 | ceramide catabolic process (GO:0046514) | 3.08212818 |
59 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.07344690 |
60 | complement activation, classical pathway (GO:0006958) | 3.04190752 |
61 | regulation of protein activation cascade (GO:2000257) | 3.02104473 |
62 | regulation of complement activation (GO:0030449) | 3.00583438 |
63 | detection of bacterium (GO:0016045) | 3.00470761 |
64 | positive regulation of interferon-alpha production (GO:0032727) | 2.99888834 |
65 | mannose metabolic process (GO:0006013) | 2.98202831 |
66 | membrane lipid catabolic process (GO:0046466) | 2.98104697 |
67 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.97613237 |
68 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.97065872 |
69 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.94922746 |
70 | myeloid cell activation involved in immune response (GO:0002275) | 2.93798008 |
71 | neutrophil activation (GO:0042119) | 2.92339334 |
72 | urea metabolic process (GO:0019627) | 2.92096497 |
73 | urea cycle (GO:0000050) | 2.92096497 |
74 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.90293009 |
75 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.89778463 |
76 | positive regulation of antigen processing and presentation (GO:0002579) | 2.89250442 |
77 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.89004037 |
78 | regulation of podosome assembly (GO:0071801) | 2.86996499 |
79 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.86632893 |
80 | hyaluronan catabolic process (GO:0030214) | 2.85162194 |
81 | cellular response to arsenic-containing substance (GO:0071243) | 2.84911482 |
82 | response to host immune response (GO:0052572) | 2.82875208 |
83 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.82875208 |
84 | sphingolipid catabolic process (GO:0030149) | 2.82707316 |
85 | response to muramyl dipeptide (GO:0032495) | 2.82098158 |
86 | regulation of interferon-alpha production (GO:0032647) | 2.81734203 |
87 | regulation of cholesterol storage (GO:0010885) | 2.81420820 |
88 | phagosome maturation (GO:0090382) | 2.81242760 |
89 | regulation of cholesterol esterification (GO:0010872) | 2.80023066 |
90 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.79624489 |
91 | regulation of gamma-delta T cell activation (GO:0046643) | 2.79179681 |
92 | keratan sulfate catabolic process (GO:0042340) | 2.78962366 |
93 | aromatic amino acid family catabolic process (GO:0009074) | 2.78778046 |
94 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.77213115 |
95 | positive regulation of heat generation (GO:0031652) | 2.76688260 |
96 | reverse cholesterol transport (GO:0043691) | 2.75532704 |
97 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.75367494 |
98 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.73193114 |
99 | regulation of chemokine biosynthetic process (GO:0045073) | 2.72181370 |
100 | plasma lipoprotein particle clearance (GO:0034381) | 2.72170920 |
101 | cholesterol efflux (GO:0033344) | 2.71591839 |
102 | basic amino acid transport (GO:0015802) | 2.71559317 |
103 | regulation of regulated secretory pathway (GO:1903305) | 2.70838883 |
104 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.70153777 |
105 | peptide hormone processing (GO:0016486) | 2.69516341 |
106 | monocyte chemotaxis (GO:0002548) | 2.67556151 |
107 | germinal center formation (GO:0002467) | 2.67102603 |
108 | neutrophil chemotaxis (GO:0030593) | 2.66934524 |
109 | negative regulation of bone resorption (GO:0045779) | 2.66912571 |
110 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.66663141 |
111 | protein activation cascade (GO:0072376) | 2.64747754 |
112 | positive regulation of interleukin-6 production (GO:0032755) | 2.64013532 |
113 | nitrogen cycle metabolic process (GO:0071941) | 2.62409832 |
114 | macrophage differentiation (GO:0030225) | 2.61196788 |
115 | positive regulation of regulated secretory pathway (GO:1903307) | 2.60983544 |
116 | detection of molecule of bacterial origin (GO:0032490) | 2.59948418 |
117 | neutrophil migration (GO:1990266) | 2.59612933 |
118 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.59231997 |
119 | positive regulation of p38MAPK cascade (GO:1900745) | 2.58708863 |
120 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.58353583 |
121 | response to host (GO:0075136) | 2.58353583 |
122 | response to host defenses (GO:0052200) | 2.58353583 |
123 | high-density lipoprotein particle remodeling (GO:0034375) | 2.57385436 |
124 | neutrophil activation involved in immune response (GO:0002283) | 2.56908077 |
125 | regulation of macrophage chemotaxis (GO:0010758) | 2.52906960 |
126 | adenosine receptor signaling pathway (GO:0001973) | 2.52670278 |
127 | negative regulation of interleukin-17 production (GO:0032700) | 2.52635060 |
128 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.52614026 |
129 | lysosome organization (GO:0007040) | 2.52250876 |
130 | lytic vacuole organization (GO:0080171) | 2.52250876 |
131 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.51982555 |
132 | regulation of interleukin-6 production (GO:0032675) | 2.51354444 |
133 | negative regulation of digestive system process (GO:0060457) | 2.50819693 |
134 | granulocyte chemotaxis (GO:0071621) | 2.50202124 |
135 | negative regulation of interleukin-1 production (GO:0032692) | 2.49968479 |
136 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.49230981 |
137 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.49119358 |
138 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.48063472 |
139 | bile acid and bile salt transport (GO:0015721) | 2.47839184 |
140 | I-kappaB phosphorylation (GO:0007252) | 2.47485011 |
141 | regulation of fever generation (GO:0031620) | 2.46415768 |
142 | response to peptidoglycan (GO:0032494) | 2.44087682 |
143 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.43803492 |
144 | lipoprotein metabolic process (GO:0042157) | 2.43750598 |
145 | regulation of antigen processing and presentation (GO:0002577) | 2.43701556 |
146 | negative regulation of tissue remodeling (GO:0034104) | 2.42611998 |
147 | respiratory burst (GO:0045730) | 2.41029513 |
148 | regulation of chemokine secretion (GO:0090196) | 2.40735655 |
149 | glomerular visceral epithelial cell development (GO:0072015) | 2.39907583 |
150 | alpha-linolenic acid metabolic process (GO:0036109) | 2.39798051 |
151 | plasma lipoprotein particle remodeling (GO:0034369) | 2.38820441 |
152 | protein-lipid complex remodeling (GO:0034368) | 2.38820441 |
153 | macromolecular complex remodeling (GO:0034367) | 2.38820441 |
154 | positive regulation of glycolytic process (GO:0045821) | 2.38084540 |
155 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.34897778 |
156 | plasma lipoprotein particle assembly (GO:0034377) | 2.34815548 |
157 | regulation of apoptotic cell clearance (GO:2000425) | 2.34774379 |
158 | positive regulation of cholesterol efflux (GO:0010875) | 2.34710415 |
159 | endocrine pancreas development (GO:0031018) | 2.34403301 |
160 | phospholipid homeostasis (GO:0055091) | 2.33649327 |
161 | negative regulation of fibrinolysis (GO:0051918) | 2.32980081 |
162 | regulation of triglyceride catabolic process (GO:0010896) | 2.32942716 |
163 | protein-lipid complex assembly (GO:0065005) | 2.32828823 |
164 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.32439165 |
165 | fibrinolysis (GO:0042730) | 2.31642221 |
166 | positive regulation of sterol transport (GO:0032373) | 2.31089301 |
167 | positive regulation of cholesterol transport (GO:0032376) | 2.31089301 |
168 | protein retention in ER lumen (GO:0006621) | 2.28433168 |
169 | glycosphingolipid catabolic process (GO:0046479) | 2.27696396 |
170 | acylglycerol homeostasis (GO:0055090) | 2.25873694 |
171 | triglyceride homeostasis (GO:0070328) | 2.25873694 |
172 | cellular extravasation (GO:0045123) | 2.25147389 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.79990570 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.08214743 |
3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.78360869 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.38729290 |
5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.32990098 |
6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.17378907 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.12683704 |
8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.07068792 |
9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.99699261 |
10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.86982559 |
11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.42628898 |
12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.38752556 |
13 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.35454010 |
14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.35443257 |
15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.08428850 |
16 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.93431897 |
17 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.87809285 |
18 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.84511900 |
19 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.84006106 |
20 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.82753500 |
21 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.78788830 |
22 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.78370637 |
23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.73923096 |
24 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.73530135 |
25 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.70205167 |
26 | GATA1_22025678_ChIP-Seq_K562_Human | 1.66097630 |
27 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.57916870 |
28 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.54989666 |
29 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.53665467 |
30 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.50451696 |
31 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.46824599 |
32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.44576310 |
33 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.44316757 |
34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.44109470 |
35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.44012328 |
36 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.43881479 |
37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.43832507 |
38 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.37698601 |
39 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.32717842 |
40 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.32168127 |
41 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.31704747 |
42 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.30968886 |
43 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.27225188 |
44 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26753855 |
45 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.26004028 |
46 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.25606217 |
47 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.25563327 |
48 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.24713592 |
49 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.23124443 |
50 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.22907887 |
51 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19494986 |
52 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.18957681 |
53 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.17770087 |
54 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.17693143 |
55 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.17135356 |
56 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.16167818 |
57 | GATA1_19941826_ChIP-Seq_K562_Human | 1.15270991 |
58 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14468072 |
59 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13970299 |
60 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.13881024 |
61 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.11448732 |
62 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.11235292 |
63 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.09954786 |
64 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.07402547 |
65 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.07333784 |
66 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07105510 |
67 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06426864 |
68 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.06292230 |
69 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.05575837 |
70 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04249893 |
71 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04210149 |
72 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.03037359 |
73 | MAF_26560356_Chip-Seq_TH1_Human | 1.02485296 |
74 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.01649058 |
75 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.01488939 |
76 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.01399910 |
77 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00872694 |
78 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00006580 |
79 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.98822735 |
80 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.98112494 |
81 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97816861 |
82 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97795394 |
83 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97657929 |
84 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97529857 |
85 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.95769940 |
86 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.95476737 |
87 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.95448446 |
88 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.94382886 |
89 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.93431234 |
90 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.93101044 |
91 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.93086250 |
92 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.92603656 |
93 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92235111 |
94 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.91857353 |
95 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.91819387 |
96 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91534726 |
97 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90648069 |
98 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.87567719 |
99 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.87396010 |
100 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87103850 |
101 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.86705145 |
102 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.86646050 |
103 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.86628311 |
104 | KDM2B_26808549_Chip-Seq_K562_Human | 0.85091775 |
105 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84923833 |
106 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.84573713 |
107 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84421584 |
108 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84294601 |
109 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.83387390 |
110 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.82736834 |
111 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.82649787 |
112 | CJUN_26792858_Chip-Seq_BT549_Human | 0.82168355 |
113 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.81833097 |
114 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81640637 |
115 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.79979565 |
116 | MYB_26560356_Chip-Seq_TH2_Human | 0.79951403 |
117 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.79498393 |
118 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.79498393 |
119 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.78368233 |
120 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.78139270 |
121 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.78015441 |
122 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.77721805 |
123 | UTX_26944678_Chip-Seq_JUKART_Human | 0.76781029 |
124 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.75995325 |
125 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.75834594 |
126 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.75237994 |
127 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.75078322 |
128 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74789157 |
129 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.74562692 |
130 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.71933223 |
131 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.71920284 |
132 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70735165 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005058_abnormal_lysosome_morphology | 3.89832854 |
2 | MP0009840_abnormal_foam_cell | 3.56155105 |
3 | MP0003191_abnormal_cellular_cholesterol | 3.41960246 |
4 | MP0003183_abnormal_peptide_metabolism | 3.31764737 |
5 | MP0005360_urolithiasis | 3.14644394 |
6 | MP0002139_abnormal_hepatobiliary_system | 3.13316476 |
7 | MP0003195_calcinosis | 2.99539847 |
8 | MP0005365_abnormal_bile_salt | 2.93724075 |
9 | MP0005085_abnormal_gallbladder_physiolo | 2.56493847 |
10 | MP0003252_abnormal_bile_duct | 2.50989254 |
11 | MP0003300_gastrointestinal_ulcer | 2.47326082 |
12 | MP0003172_abnormal_lysosome_physiology | 2.47012472 |
13 | MP0009785_altered_susceptibility_to | 2.46261739 |
14 | MP0006082_CNS_inflammation | 2.45620312 |
15 | MP0003724_increased_susceptibility_to | 2.44741678 |
16 | MP0000013_abnormal_adipose_tissue | 2.43513930 |
17 | MP0003303_peritoneal_inflammation | 2.37850425 |
18 | MP0002138_abnormal_hepatobiliary_system | 2.30482921 |
19 | MP0003436_decreased_susceptibility_to | 2.21475439 |
20 | MP0005670_abnormal_white_adipose | 2.01700688 |
21 | MP0005167_abnormal_blood-brain_barrier | 2.00381592 |
22 | MP0008875_abnormal_xenobiotic_pharmacok | 1.98795061 |
23 | MP0002419_abnormal_innate_immunity | 1.93787483 |
24 | MP0001835_abnormal_antigen_presentation | 1.93045060 |
25 | MP0010329_abnormal_lipoprotein_level | 1.92714774 |
26 | MP0009764_decreased_sensitivity_to | 1.81757331 |
27 | MP0004019_abnormal_vitamin_homeostasis | 1.81035906 |
28 | MP0001533_abnormal_skeleton_physiology | 1.72659797 |
29 | MP0009278_abnormal_bone_marrow | 1.69547904 |
30 | MP0010368_abnormal_lymphatic_system | 1.69191113 |
31 | MP0002837_dystrophic_cardiac_calcinosis | 1.68404885 |
32 | MP0003828_pulmonary_edema | 1.62659120 |
33 | MP0003690_abnormal_glial_cell | 1.57658388 |
34 | MP0003075_altered_response_to | 1.52659606 |
35 | MP0001853_heart_inflammation | 1.52104910 |
36 | MP0005464_abnormal_platelet_physiology | 1.51867058 |
37 | MP0002148_abnormal_hypersensitivity_rea | 1.50456597 |
38 | MP0005257_abnormal_intraocular_pressure | 1.50112682 |
39 | MP0000609_abnormal_liver_physiology | 1.47661776 |
40 | MP0008469_abnormal_protein_level | 1.45785237 |
41 | MP0009643_abnormal_urine_homeostasis | 1.42561408 |
42 | MP0000003_abnormal_adipose_tissue | 1.42347527 |
43 | MP0005000_abnormal_immune_tolerance | 1.40737475 |
44 | MP0002254_reproductive_system_inflammat | 1.34936909 |
45 | MP0002693_abnormal_pancreas_physiology | 1.34199614 |
46 | MP0010234_abnormal_vibrissa_follicle | 1.33519240 |
47 | MP0005387_immune_system_phenotype | 1.33431102 |
48 | MP0001790_abnormal_immune_system | 1.33431102 |
49 | MP0002118_abnormal_lipid_homeostasis | 1.32119774 |
50 | MP0002909_abnormal_adrenal_gland | 1.30775793 |
51 | MP0003705_abnormal_hypodermis_morpholog | 1.29791410 |
52 | MP0005397_hematopoietic_system_phenotyp | 1.25990751 |
53 | MP0001545_abnormal_hematopoietic_system | 1.25990751 |
54 | MP0002998_abnormal_bone_remodeling | 1.25567194 |
55 | MP0000604_amyloidosis | 1.25369566 |
56 | MP0004130_abnormal_muscle_cell | 1.24572534 |
57 | MP0008004_abnormal_stomach_pH | 1.22423369 |
58 | MP0001666_abnormal_nutrient_absorption | 1.22220005 |
59 | MP0001845_abnormal_inflammatory_respons | 1.20936705 |
60 | MP0004947_skin_inflammation | 1.20034065 |
61 | MP0010155_abnormal_intestine_physiology | 1.19975587 |
62 | MP0005025_abnormal_response_to | 1.19183740 |
63 | MP0008438_abnormal_cutaneous_collagen | 1.18981368 |
64 | MP0003448_altered_tumor_morphology | 1.18498001 |
65 | MP0003656_abnormal_erythrocyte_physiolo | 1.17893703 |
66 | * MP0005332_abnormal_amino_acid | 1.14227144 |
67 | MP0000920_abnormal_myelination | 1.13232547 |
68 | MP0005375_adipose_tissue_phenotype | 1.11779038 |
69 | MP0002078_abnormal_glucose_homeostasis | 1.11332579 |
70 | MP0002452_abnormal_antigen_presenting | 1.10679069 |
71 | MP0002928_abnormal_bile_duct | 1.10450275 |
72 | MP0002277_abnormal_respiratory_mucosa | 1.10036791 |
73 | MP0001851_eye_inflammation | 1.09236350 |
74 | MP0005451_abnormal_body_composition | 1.08507837 |
75 | MP0003329_amyloid_beta_deposits | 1.08440188 |
76 | MP0008260_abnormal_autophagy | 1.08257515 |
77 | MP0000343_altered_response_to | 1.06912245 |
78 | MP0000858_altered_metastatic_potential | 1.05011638 |
79 | MP0000465_gastrointestinal_hemorrhage | 1.03310587 |
80 | MP0006054_spinal_hemorrhage | 1.02745457 |
81 | * MP0001756_abnormal_urination | 1.02520698 |
82 | MP0002723_abnormal_immune_serum | 1.02178686 |
83 | MP0004510_myositis | 1.01200304 |
84 | MP0003566_abnormal_cell_adhesion | 1.00912802 |
85 | MP0005164_abnormal_response_to | 0.99852275 |
86 | MP0005220_abnormal_exocrine_pancreas | 0.99406030 |
87 | MP0008961_abnormal_basal_metabolism | 0.96942230 |
88 | MP0005319_abnormal_enzyme/_coenzyme | 0.96006527 |
89 | MP0001800_abnormal_humoral_immune | 0.94129011 |
90 | MP0002090_abnormal_vision | 0.93671805 |
91 | MP0010386_abnormal_urinary_bladder | 0.93028267 |
92 | * MP0001944_abnormal_pancreas_morphology | 0.92837940 |
93 | MP0005166_decreased_susceptibility_to | 0.92034782 |
94 | MP0002933_joint_inflammation | 0.91961065 |
95 | MP0009763_increased_sensitivity_to | 0.91384113 |
96 | MP0002971_abnormal_brown_adipose | 0.91161324 |
97 | MP0005671_abnormal_response_to | 0.91113695 |
98 | MP0005379_endocrine/exocrine_gland_phen | 0.91053426 |
99 | MP0000716_abnormal_immune_system | 0.90496115 |
100 | * MP0002136_abnormal_kidney_physiology | 0.89986940 |
101 | MP0009333_abnormal_splenocyte_physiolog | 0.89804392 |
102 | MP0005334_abnormal_fat_pad | 0.88646336 |
103 | MP0005645_abnormal_hypothalamus_physiol | 0.88035551 |
104 | MP0003795_abnormal_bone_structure | 0.87776853 |
105 | MP0005083_abnormal_biliary_tract | 0.87179756 |
106 | MP0002896_abnormal_bone_mineralization | 0.85504240 |
107 | MP0005390_skeleton_phenotype | 0.84824650 |
108 | MP0002877_abnormal_melanocyte_morpholog | 0.83794724 |
109 | * MP0009642_abnormal_blood_homeostasis | 0.83509699 |
110 | MP0000685_abnormal_immune_system | 0.82492064 |
111 | MP0005084_abnormal_gallbladder_morpholo | 0.82386575 |
112 | MP0003806_abnormal_nucleotide_metabolis | 0.81251430 |
113 | MP0005275_abnormal_skin_tensile | 0.80962015 |
114 | MP0004883_abnormal_blood_vessel | 0.80251868 |
115 | MP0000230_abnormal_systemic_arterial | 0.79952183 |
116 | MP0005310_abnormal_salivary_gland | 0.78036158 |
117 | MP0000598_abnormal_liver_morphology | 0.77943736 |
118 | MP0001819_abnormal_immune_cell | 0.77882589 |
119 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.77687230 |
120 | MP0002420_abnormal_adaptive_immunity | 0.75956159 |
121 | MP0000249_abnormal_blood_vessel | 0.75878579 |
122 | MP0000767_abnormal_smooth_muscle | 0.75773432 |
123 | MP0000678_abnormal_parathyroid_gland | 0.75705381 |
124 | MP0004185_abnormal_adipocyte_glucose | 0.75610406 |
125 | MP0005647_abnormal_sex_gland | 0.74750706 |
126 | MP0002405_respiratory_system_inflammati | 0.74717648 |
127 | MP0003453_abnormal_keratinocyte_physiol | 0.73997027 |
128 | MP0005165_increased_susceptibility_to | 0.71773805 |
129 | MP0005535_abnormal_body_temperature | 0.70238126 |
130 | * MP0003633_abnormal_nervous_system | 0.67151406 |
131 | MP0003879_abnormal_hair_cell | 0.66723078 |
132 | MP0000689_abnormal_spleen_morphology | 0.66039103 |
133 | MP0002332_abnormal_exercise_endurance | 0.65889553 |
134 | MP0003634_abnormal_glial_cell | 0.65824722 |
135 | MP0001542_abnormal_bone_strength | 0.63483240 |
136 | MP0000015_abnormal_ear_pigmentation | 0.63480398 |
137 | MP0002429_abnormal_blood_cell | 0.60922971 |
138 | MP0000371_diluted_coat_color | 0.56288945 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Systemic lupus erythematosus (HP:0002725) | 8.47129567 |
2 | Glomerulonephritis (HP:0000099) | 7.27769069 |
3 | Complement deficiency (HP:0004431) | 6.69065563 |
4 | Abnormality of complement system (HP:0005339) | 5.58800104 |
5 | Dysostosis multiplex (HP:0000943) | 5.00575981 |
6 | Retinal atrophy (HP:0001105) | 4.42028673 |
7 | Vacuolated lymphocytes (HP:0001922) | 4.19180815 |
8 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.19160162 |
9 | Mucopolysacchariduria (HP:0008155) | 4.19160162 |
10 | Abnormality of glycolipid metabolism (HP:0010969) | 4.13138119 |
11 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.13138119 |
12 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.13138119 |
13 | Nephritis (HP:0000123) | 4.11582791 |
14 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.96330460 |
15 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.96330460 |
16 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.96330460 |
17 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.89885859 |
18 | Increased cerebral lipofuscin (HP:0011813) | 3.83665334 |
19 | Hypoglycemic seizures (HP:0002173) | 3.75714018 |
20 | Hypoglycemic coma (HP:0001325) | 3.70768339 |
21 | Stomatitis (HP:0010280) | 3.60091411 |
22 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.52652813 |
23 | Xanthomatosis (HP:0000991) | 3.50257596 |
24 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.45975135 |
25 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.42494175 |
26 | Eczematoid dermatitis (HP:0000976) | 3.30713677 |
27 | Deep venous thrombosis (HP:0002625) | 3.29741810 |
28 | Nuclear cataract (HP:0100018) | 3.24644295 |
29 | Orchitis (HP:0100796) | 3.23276819 |
30 | Recurrent abscess formation (HP:0002722) | 3.18096324 |
31 | Recurrent bacterial skin infections (HP:0005406) | 3.15601516 |
32 | Joint hemorrhage (HP:0005261) | 3.14403074 |
33 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.12877290 |
34 | Myositis (HP:0100614) | 3.09946202 |
35 | Hyperglycemia (HP:0003074) | 3.06271741 |
36 | Axonal loss (HP:0003447) | 3.05315294 |
37 | Symptomatic seizures (HP:0011145) | 3.04940470 |
38 | Retrobulbar optic neuritis (HP:0100654) | 3.04264295 |
39 | Optic neuritis (HP:0100653) | 3.04264295 |
40 | Myocardial infarction (HP:0001658) | 3.00927159 |
41 | Late onset (HP:0003584) | 2.93246960 |
42 | Ketoacidosis (HP:0001993) | 2.81781416 |
43 | Mediastinal lymphadenopathy (HP:0100721) | 2.79990117 |
44 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.74392818 |
45 | Prolonged partial thromboplastin time (HP:0003645) | 2.73905273 |
46 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.73353047 |
47 | Pathologic fracture (HP:0002756) | 2.69294649 |
48 | Increased serum ferritin (HP:0003281) | 2.58945928 |
49 | Purpura (HP:0000979) | 2.56108530 |
50 | Malnutrition (HP:0004395) | 2.54987491 |
51 | Abnormality of the common coagulation pathway (HP:0010990) | 2.49912308 |
52 | Hyperlipoproteinemia (HP:0010980) | 2.49442192 |
53 | Metaphyseal irregularity (HP:0003025) | 2.48235121 |
54 | Striae distensae (HP:0001065) | 2.46153053 |
55 | Ketosis (HP:0001946) | 2.42781088 |
56 | Diminished motivation (HP:0000745) | 2.42588297 |
57 | Autoimmune thrombocytopenia (HP:0001973) | 2.42479916 |
58 | Progressive neurologic deterioration (HP:0002344) | 2.41884636 |
59 | Apathy (HP:0000741) | 2.40567977 |
60 | Cerebral aneurysm (HP:0004944) | 2.39318192 |
61 | Intrahepatic cholestasis (HP:0001406) | 2.39051517 |
62 | Increased CSF protein (HP:0002922) | 2.39008477 |
63 | Conjugated hyperbilirubinemia (HP:0002908) | 2.36862991 |
64 | Cardiomegaly (HP:0001640) | 2.35850453 |
65 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.35088579 |
66 | Spontaneous hematomas (HP:0007420) | 2.34084301 |
67 | Mitral stenosis (HP:0001718) | 2.31436944 |
68 | Amyloidosis (HP:0011034) | 2.30801025 |
69 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.30633645 |
70 | Increased IgE level (HP:0003212) | 2.27074258 |
71 | Asymmetric septal hypertrophy (HP:0001670) | 2.26426177 |
72 | Episodic fever (HP:0001954) | 2.26302344 |
73 | Inappropriate behavior (HP:0000719) | 2.25598218 |
74 | Thick nail (HP:0001805) | 2.24477487 |
75 | Skin nodule (HP:0200036) | 2.24419791 |
76 | Hematochezia (HP:0002573) | 2.20891613 |
77 | Arterial tortuosity (HP:0005116) | 2.20835036 |
78 | Abnormality of iron homeostasis (HP:0011031) | 2.19903205 |
79 | Polyneuropathy (HP:0001271) | 2.19661054 |
80 | Gingivitis (HP:0000230) | 2.17999122 |
81 | Epidermoid cyst (HP:0200040) | 2.16112556 |
82 | Obstructive lung disease (HP:0006536) | 2.15780139 |
83 | Chronic obstructive pulmonary disease (HP:0006510) | 2.15780139 |
84 | Loss of speech (HP:0002371) | 2.12729877 |
85 | Hypercholesterolemia (HP:0003124) | 2.11292548 |
86 | Hemoptysis (HP:0002105) | 2.09787729 |
87 | Petechiae (HP:0000967) | 2.09621258 |
88 | Abnormality of macrophages (HP:0004311) | 2.09264167 |
89 | J-shaped sella turcica (HP:0002680) | 2.08992819 |
90 | Peripheral demyelination (HP:0011096) | 2.07987054 |
91 | Disinhibition (HP:0000734) | 2.07575183 |
92 | Abnormality of the intrinsic pathway (HP:0010989) | 2.07384230 |
93 | Cerebral inclusion bodies (HP:0100314) | 2.05613225 |
94 | Tetany (HP:0001281) | 2.04572303 |
95 | Pulmonary infiltrates (HP:0002113) | 2.04294206 |
96 | Agitation (HP:0000713) | 2.02947104 |
97 | Hypoalphalipoproteinemia (HP:0003233) | 2.01959903 |
98 | Keratoconjunctivitis sicca (HP:0001097) | 2.00469471 |
99 | Dementia (HP:0000726) | 1.99315971 |
100 | Spondylolisthesis (HP:0003302) | 1.98620034 |
101 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.98088778 |
102 | Urticaria (HP:0001025) | 1.97132108 |
103 | Global brain atrophy (HP:0002283) | 1.96519851 |
104 | Mutism (HP:0002300) | 1.93981035 |
105 | Periodontitis (HP:0000704) | 1.93315117 |
106 | Prolonged neonatal jaundice (HP:0006579) | 1.93172495 |
107 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.91965714 |
108 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.91965714 |
109 | Recurrent fungal infections (HP:0002841) | 1.90341812 |
110 | Vascular tortuosity (HP:0004948) | 1.87696589 |
111 | Vasculitis (HP:0002633) | 1.87380137 |
112 | Neurofibrillary tangles (HP:0002185) | 1.87157957 |
113 | Keratoconjunctivitis (HP:0001096) | 1.84911763 |
114 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.84179284 |
115 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.83541882 |
116 | Tetraparesis (HP:0002273) | 1.82393665 |
117 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.82336159 |
118 | Hypophosphatemia (HP:0002148) | 1.82297244 |
119 | Agnosia (HP:0010524) | 1.81262596 |
120 | Upper motor neuron abnormality (HP:0002127) | 1.81126009 |
121 | Orthostatic hypotension (HP:0001278) | 1.80919748 |
122 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.80736491 |
123 | Recurrent skin infections (HP:0001581) | 1.80443121 |
124 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.80425843 |
125 | Bone cyst (HP:0012062) | 1.79968364 |
126 | Bone pain (HP:0002653) | 1.78587282 |
127 | Ovoid vertebral bodies (HP:0003300) | 1.78391041 |
128 | Progressive visual loss (HP:0000529) | 1.77249258 |
129 | Thoracic kyphosis (HP:0002942) | 1.76931488 |
130 | Polygenic inheritance (HP:0010982) | 1.75750344 |
131 | Hepatosplenomegaly (HP:0001433) | 1.75557178 |
132 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.75278254 |
133 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.74069042 |
134 | Gingival bleeding (HP:0000225) | 1.73838542 |
135 | Acne (HP:0001061) | 1.73246086 |
136 | Hypolipoproteinemia (HP:0010981) | 1.73184078 |
137 | Supranuclear gaze palsy (HP:0000605) | 1.71532386 |
138 | Personality changes (HP:0000751) | 1.70397201 |
139 | Esophageal varix (HP:0002040) | 1.66297333 |
140 | Hypobetalipoproteinemia (HP:0003563) | 1.65006176 |
141 | Neuronal loss in central nervous system (HP:0002529) | 1.64808635 |
142 | Pulmonary embolism (HP:0002204) | 1.64563131 |
143 | Vertigo (HP:0002321) | 1.64496265 |
144 | Premature loss of primary teeth (HP:0006323) | 1.64262127 |
145 | Colitis (HP:0002583) | 1.64128496 |
146 | Basal ganglia calcification (HP:0002135) | 1.64033423 |
147 | Abnormality of the basal ganglia (HP:0002134) | 1.62824106 |
148 | Abdominal distention (HP:0003270) | 1.62113556 |
149 | Growth hormone excess (HP:0000845) | 1.61170468 |
150 | Large for gestational age (HP:0001520) | 1.60654998 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAPK15 | 7.09261799 |
2 | TGFBR2 | 4.26505983 |
3 | ERN1 | 3.60190589 |
4 | PIK3CG | 3.42248810 |
5 | INSRR | 2.92289322 |
6 | BLK | 2.79329110 |
7 | WNK3 | 2.74343399 |
8 | TAOK3 | 2.16907186 |
9 | TYK2 | 2.13062086 |
10 | GRK7 | 2.07504243 |
11 | PRPF4B | 2.06079262 |
12 | TAOK1 | 2.05154714 |
13 | FGR | 2.02697182 |
14 | EPHA3 | 1.95338762 |
15 | IRAK3 | 1.91548270 |
16 | EPHB1 | 1.90338685 |
17 | DDR2 | 1.83743119 |
18 | CAMK1D | 1.74781602 |
19 | IRAK4 | 1.63504881 |
20 | FGFR4 | 1.56665318 |
21 | CSF1R | 1.55594451 |
22 | TBK1 | 1.55413332 |
23 | NME2 | 1.54364499 |
24 | CSK | 1.47831342 |
25 | PTK6 | 1.44834104 |
26 | JAK1 | 1.44057177 |
27 | FRK | 1.42277422 |
28 | ACVR1B | 1.40440497 |
29 | TRIB3 | 1.35869496 |
30 | CAMK1G | 1.32444633 |
31 | TAOK2 | 1.31871533 |
32 | PDK2 | 1.31453157 |
33 | CDC42BPA | 1.28054921 |
34 | SIK1 | 1.26020132 |
35 | KDR | 1.25658017 |
36 | TNK2 | 1.23603547 |
37 | RIPK1 | 1.18907585 |
38 | MST1R | 1.17029565 |
39 | MAP3K14 | 1.14011135 |
40 | BMPR2 | 1.10465330 |
41 | PAK4 | 1.10328770 |
42 | RIPK4 | 1.10119231 |
43 | WNK4 | 1.09146589 |
44 | JAK2 | 1.05532971 |
45 | DYRK1B | 1.04492017 |
46 | MAP2K6 | 1.03337579 |
47 | ABL2 | 1.02544332 |
48 | KIT | 0.99081838 |
49 | IRAK1 | 0.99065918 |
50 | ZAP70 | 0.98929910 |
51 | STK24 | 0.96296093 |
52 | CAMKK2 | 0.95242853 |
53 | TESK1 | 0.92809890 |
54 | NEK9 | 0.90684900 |
55 | MAP4K1 | 0.89553760 |
56 | MAP3K1 | 0.89460839 |
57 | MAP3K2 | 0.89076831 |
58 | MAP3K3 | 0.84513223 |
59 | HIPK2 | 0.84485724 |
60 | MAP2K2 | 0.83802871 |
61 | TXK | 0.80840059 |
62 | HCK | 0.76532208 |
63 | ITK | 0.73425203 |
64 | PRKD2 | 0.69538095 |
65 | PKN2 | 0.66814123 |
66 | FGFR3 | 0.64412118 |
67 | BTK | 0.64163728 |
68 | PDK1 | 0.63064627 |
69 | PIM2 | 0.62536198 |
70 | GSK3A | 0.62267937 |
71 | FLT3 | 0.62209154 |
72 | TGFBR1 | 0.61731396 |
73 | LYN | 0.61227198 |
74 | TIE1 | 0.60744117 |
75 | IKBKB | 0.60460187 |
76 | IGF1R | 0.60448489 |
77 | MAP3K10 | 0.59972415 |
78 | ADRBK2 | 0.58681286 |
79 | CHUK | 0.58093128 |
80 | PTK2 | 0.57681731 |
81 | TRPM7 | 0.56856091 |
82 | SIK3 | 0.56194749 |
83 | DAPK2 | 0.55388211 |
84 | MAP2K3 | 0.54897957 |
85 | MAPK7 | 0.54600984 |
86 | EPHA2 | 0.54098131 |
87 | SCYL2 | 0.54073449 |
88 | MARK2 | 0.53056512 |
89 | IKBKE | 0.50604323 |
90 | MAP3K11 | 0.49912177 |
91 | FER | 0.49319561 |
92 | YES1 | 0.48174048 |
93 | BCKDK | 0.46997486 |
94 | EPHB2 | 0.46996818 |
95 | CAMK4 | 0.46938143 |
96 | CAMKK1 | 0.46284889 |
97 | CDK6 | 0.46033024 |
98 | JAK3 | 0.46029277 |
99 | MAP3K5 | 0.45332544 |
100 | MET | 0.45037465 |
101 | KSR2 | 0.44951239 |
102 | ARAF | 0.44735935 |
103 | LCK | 0.43376019 |
104 | MAPKAPK2 | 0.43212973 |
105 | MAPK12 | 0.42989806 |
106 | RPS6KL1 | 0.42431415 |
107 | RPS6KC1 | 0.42431415 |
108 | ABL1 | 0.42202297 |
109 | MATK | 0.41847536 |
110 | FES | 0.41748472 |
111 | EGFR | 0.41013532 |
112 | PRKCH | 0.40189778 |
113 | PDGFRB | 0.38510968 |
114 | SIK2 | 0.36773840 |
115 | MAPK4 | 0.36596876 |
116 | MOS | 0.35175765 |
117 | PRKAA2 | 0.35026424 |
118 | SYK | 0.34672844 |
119 | PRKD1 | 0.33792253 |
120 | RPS6KA6 | 0.33379717 |
121 | TSSK6 | 0.33164844 |
122 | MAP3K6 | 0.32887023 |
123 | TEC | 0.31542252 |
124 | PDPK1 | 0.30702964 |
125 | MAPK11 | 0.30689750 |
126 | STK10 | 0.30647616 |
127 | SGK2 | 0.30035017 |
128 | CDK3 | 0.29898388 |
129 | NLK | 0.29635681 |
130 | RPS6KA2 | 0.29380534 |
131 | MAP3K13 | 0.28724762 |
132 | IRAK2 | 0.27872334 |
133 | PAK2 | 0.27410166 |
134 | MARK3 | 0.26415580 |
135 | SGK3 | 0.26183034 |
136 | MAP2K4 | 0.25964801 |
137 | PDGFRA | 0.25721298 |
138 | FYN | 0.24810772 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.88928847 |
2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.62141421 |
3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.48699202 |
4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.19841840 |
5 | Other glycan degradation_Homo sapiens_hsa00511 | 3.13014989 |
6 | Lysosome_Homo sapiens_hsa04142 | 2.73003127 |
7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.36081196 |
8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.32098880 |
9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.06404754 |
10 | Prion diseases_Homo sapiens_hsa05020 | 2.02267995 |
11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.96994618 |
12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.78280519 |
13 | Pertussis_Homo sapiens_hsa05133 | 1.72563823 |
14 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.71327528 |
15 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.70325466 |
16 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.69625852 |
17 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.69048904 |
18 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.67234859 |
19 | Asthma_Homo sapiens_hsa05310 | 1.65513942 |
20 | ABC transporters_Homo sapiens_hsa02010 | 1.63472887 |
21 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.63341351 |
22 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.61249549 |
23 | Allograft rejection_Homo sapiens_hsa05330 | 1.58548256 |
24 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.47617678 |
25 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.43756621 |
26 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.37352073 |
27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.35173260 |
28 | Leishmaniasis_Homo sapiens_hsa05140 | 1.33264482 |
29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.32264253 |
30 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.29734895 |
31 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.17929916 |
32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.17203986 |
33 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.15210140 |
34 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.13752041 |
35 | Legionellosis_Homo sapiens_hsa05134 | 1.11092226 |
36 | Phagosome_Homo sapiens_hsa04145 | 1.06360313 |
37 | Tuberculosis_Homo sapiens_hsa05152 | 1.04712831 |
38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.02739064 |
39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.02052734 |
40 | Peroxisome_Homo sapiens_hsa04146 | 1.02002840 |
41 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.96355425 |
42 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.96310239 |
43 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.90519044 |
44 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.90373576 |
45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.89142946 |
46 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.87054800 |
47 | Malaria_Homo sapiens_hsa05144 | 0.86756683 |
48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.82501887 |
49 | Bile secretion_Homo sapiens_hsa04976 | 0.79950666 |
50 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.79895538 |
51 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.78644811 |
52 | Hepatitis C_Homo sapiens_hsa05160 | 0.76399804 |
53 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.75765175 |
54 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.74624023 |
55 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.74149233 |
56 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.73921014 |
57 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72613400 |
58 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.71953896 |
59 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.71611189 |
60 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.70213116 |
61 | Shigellosis_Homo sapiens_hsa05131 | 0.70130142 |
62 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69166891 |
63 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.68757070 |
64 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.67186260 |
65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.66531816 |
66 | Amoebiasis_Homo sapiens_hsa05146 | 0.65880940 |
67 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.65746444 |
68 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.65654987 |
69 | Lysine degradation_Homo sapiens_hsa00310 | 0.64360495 |
70 | Bladder cancer_Homo sapiens_hsa05219 | 0.64088585 |
71 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.63195965 |
72 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.63015258 |
73 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.62702904 |
74 | Viral myocarditis_Homo sapiens_hsa05416 | 0.62696589 |
75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62047317 |
76 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.62047297 |
77 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.61725256 |
78 | Protein export_Homo sapiens_hsa03060 | 0.61364778 |
79 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.60388176 |
80 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.59246107 |
81 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.59157611 |
82 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58813870 |
83 | Insulin resistance_Homo sapiens_hsa04931 | 0.58647290 |
84 | Hepatitis B_Homo sapiens_hsa05161 | 0.58608857 |
85 | Retinol metabolism_Homo sapiens_hsa00830 | 0.55424623 |
86 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.55340999 |
87 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.54287111 |
88 | Insulin secretion_Homo sapiens_hsa04911 | 0.54183843 |
89 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.54052543 |
90 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.51237263 |
91 | Platelet activation_Homo sapiens_hsa04611 | 0.50301949 |
92 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.49486993 |
93 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.46685591 |
94 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.46374233 |
95 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46348472 |
96 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.46334225 |
97 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.46142062 |
98 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.45304349 |
99 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45037556 |
100 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44048112 |
101 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42660928 |
102 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.42597049 |
103 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.42286580 |
104 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.42106519 |
105 | Endocytosis_Homo sapiens_hsa04144 | 0.41394250 |
106 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.40502483 |
107 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.40281822 |
108 | Renin secretion_Homo sapiens_hsa04924 | 0.39867068 |
109 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.39673949 |
110 | Salmonella infection_Homo sapiens_hsa05132 | 0.37957196 |
111 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.36309857 |
112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35986414 |
113 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.35445528 |
114 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.34821038 |
115 | Measles_Homo sapiens_hsa05162 | 0.34419883 |
116 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.33880327 |
117 | Mineral absorption_Homo sapiens_hsa04978 | 0.33731886 |
118 | Apoptosis_Homo sapiens_hsa04210 | 0.33554768 |
119 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.33465806 |
120 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.33429163 |
121 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.32239676 |
122 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31644435 |
123 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31640597 |
124 | Influenza A_Homo sapiens_hsa05164 | 0.30996729 |
125 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.30873620 |
126 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.30166206 |
127 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.29919892 |
128 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.29734008 |
129 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.28765270 |
130 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.28756844 |
131 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.28519787 |
132 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.28051007 |
133 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.27800029 |
134 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.27746156 |
135 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.27423125 |
136 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26997118 |
137 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.26425111 |
138 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.26081882 |
139 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.25568833 |
140 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.24788160 |
141 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.24746871 |
142 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.24457490 |
143 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.22328960 |